Pharmaceutical development

A research programme open to the right partner

The ErpeCream Investigational Pharmaceutical Development Programme is presented here as separate from ErpeCream / E-Cream cosmetic product commercialization. ACS Biomed is exploring pharmaceutical licensing and co-development opportunities around proprietary formulation research, laboratory investigations and preliminary clinical research.

Proprietary formulation research

The programme is built around a proprietary topical formulation platform and the research questions documented in the existing scientific materials.

Laboratory and clinical work

Existing project materials describe laboratory investigations and preliminary clinical research. The current page does not add a new trial status, location, recruitment figure or approval claim.

Development objectives

The objective is to establish an evidence-led path for future pharmaceutical development with an experienced licensing or co-development partner.

Opportunity areas

  • Pharmaceutical licensing
  • Co-development and clinical strategy
  • Regulatory and CMC collaboration

Important distinction

  • ErpeCream is an investigational programme here
  • E-Cream and E-Lip are the current cosmetic product names
  • No approved medicinal indication is asserted on this page